Haematology Critical Ranges: Difference between revisions
Created blank page |
added references |
||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{| class="wikitable" | |||
! colspan="2" | | |||
=== Haemoglobin === | |||
|- | |||
| valign="top" |Inpatients | |||
| valign="top" |'''< 70 g/L''' | |||
|- | |||
| valign="top" |GP/OPD | |||
| valign="top" |'''< 80 g/L and > 200 g/L''' | |||
|- | |||
! colspan="2" valign="top" | | |||
=== Neutrophils === | |||
|- | |||
| valign="top" |Inpatients | |||
| valign="top" |'''< 0.5 x 10(9)/L''' | |||
|- | |||
| valign="top" |GP/OPD | |||
| valign="top" |'''< 0.5 x10(9)/L and >20 x10(9)/L''' | |||
|- | |||
! colspan="2" valign="top" | | |||
=== Platelets === | |||
|- | |||
| valign="top" |Pregnant | |||
| valign="top" |'''< 80 x 10(9)/L''' | |||
|- | |||
| valign="top" |Inpatients | |||
| valign="top" |'''< 80 x 10(9)/L''' | |||
|- | |||
| valign="top" |GP/OPD | |||
| valign="top" |'''< 30 x10(9)/L and >1000 x10(9)/L''' | |||
|- | |||
! colspan="2" valign="top" | | |||
=== Coagulation === | |||
|- | |||
| valign="top" |INR (on Warfarin) | |||
| valign="top" |'''≥ 5.0''' | |||
|- | |||
| valign="top" |APTT (on Heparin) | |||
| valign="top" |'''≥ 105 seconds''' | |||
|- | |||
| valign="top" |APTT (on Dabigatran) | |||
| valign="top" |'''≥ 80 seconds''' | |||
|- | |||
| valign="top" |Fibrinogen | |||
| valign="top" |'''≤ 1.0 g/L''' | |||
|- | |||
! colspan="2" valign="top" | | |||
=== Malaria Antigen/NAAT === | |||
|- | |||
| valign="top" | | |||
|'''Positive''' | |||
|} | |||
<small>References:</small> | |||
<small>New Zealand Haematology Quality Assurance Group (NZHQAG). (2025) ''Critical limit recommendations''</small> | |||
<small>Reviewed by Dr. Kim Nash,</small> <small>Haematologist, Awanui laboratories, Auckland. 03/11/2026</small> | |||